Why the Pharma Industry is Struggling to Find the Right Executives In 2026

Executive hiring in U.S. pharma is taking longer, shortlists are thinner, finalists hesitate and boards second-guess. It is easy to blame “talent shortages” but what’s actually happening is more specific. The job has changed faster than the candidate pool has evolved. Boards now expect one executive to carry scientific credibility, financial discipline, and regulatory judgment...

How to Reduce Late-Stage Candidate Dropouts in R&D Hiring: Lessons from Recent Placements

Hiring leaders across U.S. R&D teams are running into a familiar problem. The candidate pipeline looks strong. Technical assessments check out. Interviews go well. Then, late in the process, momentum breaks. Offers stall. Candidates hesitate. Some walk away entirely. This pattern is not driven by compensation alone or by skill mismatches. Recent placements across research,...